SCHEMBL9796235

SCHEMBL9796235

CCCN(CCC)S(=O)(=O)c1ccc(C)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 5/20 0.56
ALDH1A1 P00352 2/20 0.56
TSHR P16473 2/20 0.47
CYP3A4 P08684 1/20 0.47
MCOLN3 Q8TDD5 1/20 0.46
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CA1 P00915 1/20 0.44
TDP1 Q9NUW8 2/20 0.42
ALDH3A1 P30838 1/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.40
NFKBIA P25963 1/20 0.40
AGTR1 P30556 1/20 0.40
OPRK1 P41145 1/20 0.40
KMT2A Q03164 1/20 0.40
RELA Q04206 1/20 0.40
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
HCAR3 P49019 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34463904 0.81 HCAR3 (0.64) VCAM1ALDH1A1TSHRCA12CA9
SCHEMBL9796226 0.80 CYP3A4 (0.55) VCAM1ALDH1A1TSHRCYP3A4MCOLN3
SCHEMBL11442096 0.78 VCAM1 (0.47) VCAM1ALDH1A1TSHRCYP3A4MCOLN3
SCHEMBL1368484 0.78 TSHR (0.51) ALDH1A1TSHRCYP3A4MCOLN3TDP1
SCHEMBL9796228 0.75 VCAM1 (0.72) VCAM1ALDH1A1MCOLN3CA12CA9
SCHEMBL4067424 0.75 TSHR (0.60) VCAM1TSHRCYP3A4MCOLN3TDP1
SCHEMBL10619019 0.75 TSHR (0.60) VCAM1TSHRCYP3A4MCOLN3TDP1
SCHEMBL13717956 0.75 VCAM1 (0.55) VCAM1ALDH1A1TSHRCYP3A4TDP1
SCHEMBL23532651 0.74 CA1 (0.52) VCAM1ALDH1A1CA12CA9CA1
SCHEMBL30029237 0.74 CA1 (0.52) VCAM1ALDH1A1CA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990523-A Treatment of chronic inflammatory joint disease with arylsulfonamides A. H. ROBINS COMPANY, INCORPORATED (US) 1991-02-05 US disclosed
WO-1990015600-A2 TREATMENT OF CHRONIC INFLAMMATORY JOINT DISEASE WITH ARYLSULFONAMIDES A.H. ROBINS COMPANY, INCORPORATED (US) 1990-12-27 WO disclosed